Explore the emerging role of psychedelics in pharmacy practice and their potential to transform mental health treatment. This episode dives into the science, safety, and regulatory considerations pharmacists need to know as these therapies move toward mainstream use. Don’t miss this opportunity to stay ahead of the curve—tune in and expand your understanding of this groundbreaking area of care!

Upon successful completion of this course, learners should be able to:
1. Explain the current evidence and therapeutic potential of psychedelics in treating mental health conditions.
2. Identify key safety, regulatory, and clinical considerations for pharmacists as psychedelics become integrated into patient care.

Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Colby Burns, PharmD
Clinical Pharmacist, CHAS Healthcare
President, Psychedelic Pharmacist Association
Owner/Host, Neural Pharm Online Platform and Podcast

Joshua Davis Kinsey and Colby Burns have no relevant financial relationships to disclose. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: January 13, 2025
Planned Expiration Date: January 13, 2026

Copyright 2025, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.